Loading...
Studies on the efficacy of selective serotonin reuptake inhibitors in treating fibromyalgia have yielded mixed results. In the current study, 60 female outpatients (age range, 21 to 71) with fibromyalgia were randomized to receive 12 weeks of fluoxetine (mean dose, 45 mg daily) or placebo. At baseline and 12 weeks, participants completed standardized symptom and function questionnaires and underwent testing for tender points.
Twelve fluoxetine recipients and 11 placebo recipients dropped out of the study. At 12 weeks, in both an intent-to-treat analysis and an analysis that included only completers, the fluoxetine group had significantly greater improvement in total fibromyalgia scores and in several symptom subscores (including pain, fatigu…